Logo

Disease Research

News and analysis on disease research and diagnostics.

Roddenberry Foundation Grants $1.2M to Elypta, Avalo, Thylacine Biosciences

Early cancer detection firm Elypta won the $1.0 million grand prize, while Thylacine Biosciences and Avalo were each awarded $100,000. 

BGI Genomics, Zentya Partner to Launch PCR Fecal Test for Colorectal Cancer in Slovakia

ColoTect 1.0 is a fecal assay that can trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples using methylation-specific PCR technology.

Genialis Closes $13M Series A Funding Round

Machine learning firm Genialis will use the new financing to beef up its ResponderID software and related catalog of clinically validated cancer biomarkers.

Acutis Diagnostics to Integrate Sophia Genetics Analytics Into Hereditary Cancer NGS Assay

Acutis will embed Sophia's DDM analytics platform into a new test to screen patients for clinical trial enrollment and support outcomes analysis.

Reactivated Promoters in Transposable Elements Help Form Unique Tumor Antigens

The finding of tumor-specific cell-surface antigens resulting from TE-chimeric transcripts lays the foundation for developing a pan-cancer vaccine, according to the authors.

Mar 28, 2023

Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies

Mar 28, 2023

Schmidt Futures Gives $50M for Life Science Research Including Single-Cell Proteomics Institute
Premium

Mar 28, 2023

Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia

Mar 28, 2023

Burning Rock Q4 Revenues Down 4 Percent Due to COVID-19 Resurgence in China

Mar 28, 2023

Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test

Mar 27, 2023

OraSure Technologies, nRichDX Collaborate on Urine Collection Device for Cell-Free DNA

Mar 27, 2023

American Heart Association Offers Guidelines on Reporting Incidental Findings of Sequencing Tests

Mar 27, 2023

Neuroblastoma Outcomes Linked to Tumor Evolution Features, Timeframe

Mar 27, 2023

Amoy Diagnostics PLC Panel Gets Approval in Japan as CDx for Retevmo in Non-Small Cell Lung Cancer

Mar 27, 2023

Transcriptomic Classification of Pediatric Cancers Shows Potential to Improve Clinical Diagnoses
Premium

Mar 27, 2023

Berry Genomics, Ajlan & Bros Form Reproductive Health Testing Joint Venture in Middle East

Mar 27, 2023

DiaSorin 2022 Revenues Grow 10 Percent

Mar 24, 2023

William Blair Initiates Coverage of MDxHealth With Outperform Rating

Mar 24, 2023

British Liquid Biopsy Firm Nonacus Launches Urine-Based Bladder Cancer Assay
Premium

Mar 24, 2023

Immunopeptidomics Firm ImmuneSpec Secures €1.2M in Seed Funding

Mar 24, 2023

White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development

Mar 24, 2023

Cancer Sequencing Panel Speeds Rapidly Improving, but Clinical Impact Studies Are Needed
Premium

Mar 23, 2023

TUM Researchers Profiling Dose-Dependent Response of Protein PTMs to Cancer Drugs
Premium

Mar 23, 2023

Medulloblastoma Long-Read Sequences Reveal Complex Rearrangements, Methylation Changes

Mar 23, 2023

Onconova Therapeutics, Pangea Biomed Collaborate on AI-Driven Cancer Biomarker Study

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.